Inhaled nitric oxide in patients with severe heart failure: Changes in lung perfusion and ventilation detected using scintigraphy

Thoracic and Cardiovascular Surgeon

Volumn 44, Issue 1, 1996, Pages 35-39

  Speziale, C ^a,c   De Biase, L ^a   De Vincentis, G ^b   Ierardi, M ^b   Ruvolo, G ^a   La Francesco, S ^a   Scopinaro, F ^b   Marino, B ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Surgery   (Italy)

Author keywords

heart transplantation; lung scintigraphy; nitric oxide; pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEART FAILURE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG SCINTISCANNING; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION;

EID: 9244264919     PISSN: 01716425     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1011980     Document Type: Article

References (36)

1. Addonizio, L., W. Gersony, R. Robbins, et al.: Elevated pulmonary vascular resistence and cardiac transplantation. Circulation 76 (1987) Suppl.V: 52-55
2. Barnes, P.J.: Nitric oxide and airways. Eur. Resp.J. 6 (1993) 163-165
3. Bigatello, L. M., W. E. Hurford, R. M. Kacmarek, J. D. Roberts, and W. M. Zapol: Prolonged inhalation of low levels of nitric oxide in patients with severe ARDS: effects on pulmonary hemodynamics and oxygenation. Anesthesiology 80 (1994) 761-770
4. Breen, P. H., P. T. Schumacker, G. Hedenstierna, J. Ali, P. D. Wagner, and L. D. H. Wood: How does increased cardiac output increase shunt in pulmonary edema? J. Appl. Physiol. 53 (1982) 1273-1280
5. Brigham, K. L., W. C. Woolverton, L. H. Blake, and N. C. Staub: Increased sheep lung vascular permeability caused by pseudomonas bacteremia. J. Clin. Invest. 63 (1974) 792-804
6. Cody, R. J., G. J. Haas, P. F. Binkley, Q. Capers, and R. Kelley: Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85 (1992) 504-509
7. Costard-Jackle, A., and M. Fowler: Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J. Am. Coll. Cardiol. 19 (1992) 48-54
8. Costard-Jackle, A., I. Hill, J. Schroeder, and M. Fowler: The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation 84 (1991) Suppl. III: 329-337
9. Deeb, G., and S. Bolling: The role of amrinone in potential heart transplant patients with pulmonary hypertension, J. Cardiothorac. Anesth. 3 (1989) 33-37
10. Fonger, J., A. Borkon, W. Baumgärtner, S. Achuff, S. Augustine, and B. Reitz: Acute right-ventricular failure following heart transplantation: improvement with prostaglandin E1 and right-ventricular assist. J. Heart Transplant. 5 (1986) 317-321
11. Francis, G. S., S. R. Goldsmith, T. B. Levine, M. T. Olivari, and J. N. Cohn: The neurohumoral axis in congestive heart failure. Ann. Intern. Med. 101 (1984) 370-377
12. Griepp, R., E. Stinson, E. Dong, D. Clark, and N. Shumway: Determinants of operative risk in human heart transplantation. Am. J. Surg. 122 (1971) 192-197
13. Ignarro, L., H. Lippton, J. Edwards, et al.: Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Then 218 (1981) 739-749
14. Kelm, M., and J. Schrader: Control of coronary vascular tone by nitric oxide. Circ. Res. 66 (1990) 1561-1575
15. Kirklin, J., D. Naftel. J. Kirklin, E. Blackstone, C. White-Williams, and R. Bourge: Pulmonary vascular resistence and the risk of heart transplantation. J. Heart Transplant. 7 (1988) 331-336
16. Lindemberg, L., A. Larsson, S. Steen, S. G. Olsson, and L Nordstrom: Nitric oxide gives maximal response after coronary artery bypass surgery. J. Cardiothor. Vase. Anesth. 8 (1994) 182-187
17. Loh, E., J. S. Stomler, J.M. Hare,J. Loscalzo, and W. S. Colucci: Cardiovascular effects of inhaled nitric oxide in patients with left-ventricular dysfunction. Circulation 90 (1994) 2780-2785
18. Lundin, S., N. Kieler-Jensen, F. Waagstein, and A. Wennmalm: Hemodynamic effects and metabolic fate of inhaled nitric oxide in patients with severe congestive heart failure. Circulation 86 (1992) Suppl. 1:770
19. Lynch, J. P., J. C. Mhyre, and D. R. Dantzker: Influence of cardiac output on intrapulmonary shunt. J. Appl. Physiol. 46 (1979) 315-321
20. Melot, C., P. Lejeune, M. Leeman, J.J. Moraine, and R. Naeije: Prostaglandin E1 in the adult respiratory distress syndrome: benefit for pulmonary hypertension and cost for pulmonary gas exchange. Am. Rev. Respir. Dis. 139 (1989) 106-110
21. Murali, S., B. Uretsky, J. Armitage, et al.: Utility of prostaglandin E1 in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J. Heart Lung Transplant. 11 (1992) 716-723
22. Palmer, R. M. J., D. S. Ashton, and S. Moncada: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333 (1988) 664-666
23. Palmer, R., D. Rees, D. Ashton, and S. Moncada: L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem. Biophys. Res. Commun. 153 (1988) 1251-1256
24. Pepke-Zaba, J., T. W. Higenbottam, A. T. Dinh Xuan, D. Stone, and J. Wallwork: Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 338 (1991) 1173-1174
25. Radermaker, P., Y. Huet, F. Pluskwa, et al.: Comparison of ketanserin and sodium nitroprusside in patients with severe ARDS. Anesthesiology 68 (1988) 152-157
26. Rademaker, P., B. Santak, H.J. Wust, J. Tarnow, and K.J. Falke: Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology 72 (1990) 238-244
27. Rimar, S., and C. N. Gillis: Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation. Circulation 88 (1993) 2884-2887
28. Roberts, J., T. Y. Chen, N. Kawai, et al.: Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb. Circ. Res. 72 (1993) 246-254
29. Roberts, J., P. Land, L Bigatello, G. Vlahakes, and W. Zapol: Inhaled nitric oxide in congenital heart disease. Circulation 87 (1993) 447-453
30. Rossaint, R., K. Falke, F. Lopez, K Slama, U. Pison, and W. Zapol: Inhaled, nitric oxide for the adult respiratory distress syndrome. N. Engl.J. Med. 328 (1993) 399-405
31. Ruvolo, G., G. Speziale, E. Greco, L. Tritapepe, V. Mollace, G. Nisticò, and B. Marino: Nitric oxide release during hypothermic versus normothermic cardiopulmonary bypass. Eur. J. Cardiothorac. Surg. (in press)
32. Semigran, M. J., B. A. Cockrill, R. Kacmarek, B. T. Thompson, W. M. Zapol, W. Dec, and M.A. Fifer: Hemodynamic effects of inhaled nitric oxide in heart failure. J. Am. Coll. Cardiol. 24 (1994) 982-988
33. Sprague, R., C. Thiemermann, and J. R. Vane: Endogenous endothelium-derived relaxing factor opposes hypoxic pulmonary vasoconstriction and supports blood flow to hypoxic alveoli in anesthetized rabbits. Proc. Natl. Acad. Sci. USA 89 (1992) 8711-8715
34. Thompson, M. E.: Selection of candidates for cardiac transplantation. J. Heart Transplant. 3 (1983) 65-69
35. Zapol, W. M., and M. T. Snider: Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296 (1977) 476-480
36. Zapol, W. M., M. T. Snider, M. A. Rie, M. Frikker, and D. A. Quinn: Pulmonary circulation during adult respiratory distress syndrome. In Zapol, W. M., K. J. Falke (eds): Acute respiratory failure. Vol 24 of 'Lung biology in health and disease'. New York, Marcel Dekker, 1985 pp. 241-273